Determining Factors for Pertussis Vaccination Policy: A Study in Five EU Countries

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 1 Feb 2020)

Open Access Article
Determining Factors for Pertussis Vaccination Policy: A Study in Five EU Countries
by Anabelle Wong , Annick Opinel , Simon Jean-Baptiste Combes , Julie Toubiana and Sylvain Brisse
Vaccines 2020, 8(1), 46; https://doi.org/10.3390/vaccines8010046 – 26 Jan 2020
Viewed by 278
Abstract
Pertussis vaccination policy varies across Europe, not only in the type of vaccine—whole cell (wP) vs. acellular (aP1/2/3/5)—but also in the schedule and recommendation for parents. This study aims to investigate the determining factors for the type of vaccine, immunization schedule and maternal immunization recommendation. From March to May 2019, experts in national health agencies and major academic or research institutions from Denmark, France, Poland, Sweden and the UK were invited to a semi-structured interview. Thematic analysis was performed on the transcripts using a codebook formulated by three coders. Inter-coder agreement was assessed. Fifteen expert interviews were conducted. The identified driving factors for pertussis vaccine policy were classified into three domains: scientific factors, sociological factors, and pragmatic factors. The determining factors for the type of vaccine were prescriber’s preference, concern of adverse events following immunization (AEFI), effectiveness, and consideration of other vaccine components in combined vaccines. The determining factors for infant schedule were immunity response and the potential to improve coverage and timeliness. The determining factors for maternal immunization were infant mortality and public acceptability. To conclude, socio-political and pragmatic factors were, besides scientific factors, important in determining the pertussis vaccine type, schedule of childhood immunization and recommendations for parents

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

American Journal of Law & Medicine
First Published January 23, 2020
Research Article
Informed Consent to Vaccination: Theoretical, Legal, and Empirical Insights
Dorit Rubinstein Reiss, Nili Karako-Eyal
https://doi.org/10.1177/0098858819892745 
Abstract
Informed consent matters — so does protecting people from infectious diseases. This paper examines what the appropriate informed consent process for vaccines should look like and how the process is conceptualized by law and health authorities. Drawing on the extensive theoretical and empirical literature on informed consent and vaccination, this article sets out what an ideal informed consent process for vaccination would consist of, highlighting the need for autonomous decisions. To be autonomous, decisions need to be based on full, accessible information and reached without coercion. We suggest that the information provided must address the nature of the procedure — including benefits to the child, benefits to society, and risks. Parents should have their concerns and misconceptions addressed. The information needs to be accessible and include an opportunity to ask questions. Based on this ideal model we examined in detail the legal framework surrounding informed consent to vaccination and the process as conceptualized by health authorities in two countries, Israel and the United States, to assess whether they meet the requirements. These two countries are similar in some of their values, for example, the importance of individual autonomy, and face similar problems related to vaccine hesitancy. At the same time, there are meaningful differences in their vaccine policies and the current structures of their informed consent processes, allowing for a meaningful comparison. We found neither country met our ideal informed consent process, and suggested improvements both to the materials and to the processes used to obtain informed consent.

 

PharmacoEconomics & Outcomes News
January 2020, Volume 845, Issue 1, pp 16–16
Clinical Study
Is adolescent immunisation for pertussis cost effective in Canada?
K Anyiwe et al
Background
Adolescent tetanus, diphtheria and pertussis (Tdap) immunization helps prevent pertussis infection. Timing of Tdap receipt represents an important facet of successful adolescent pertussis immunization. Potential strategies for timing of vaccine administration are each associated with different benefits – including disease prevention – and costs. The objective of this study was to assess the cost-utility of adolescent pertussis immunization strategies in Canada.
Conclusion
Analysis assumes a policy context where immunization of pregnant women is recommended. Findings suggest that alternate adolescent Tdap vaccine strategies – either immunization of 10 year olds, or removal of the adolescent vaccine – are more cost-effective than the current practice of immunizing 14 year olds.

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 1 Feb 2020
Ideas
Coronavirus Is Coming—And Trump Isn’t Ready
In order to combat the disease, the president will have to trust the kind of government experts he has disdained and dismissed.
January 30, 2020

 

BBC
http://www.bbc.co.uk/
Accessed 1 Feb 2020
Published Date 30 Jan 2020
Coronavirus: The US laboratory developing a vaccine

 

The Economist
http://www.economist.com/
Accessed 1 Feb 2020
[No new, unique, relevant content]

 

Financial Times
http://www.ft.com/home/uk
Coronavirus
The scientist leading the coronavirus vaccine race [CEPI]

Pharmaceutical companies work to repurpose existing genetic technology
January 30, 2020

 

Forbes
http://www.forbes.com/
[No new, unique, relevant content]

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 1 Feb 2020
China  
Jan 31, 2020 Snapshot
How to Prepare for a Coronavirus Pandemic
A roadmap for the worst-case scenario.
Tom Inglesby

 

Foreign Policy
http://foreignpolicy.com/
Accessed 1 Feb 2020
What Can Be Done to Stop the Wuhan Virus
In a special conference call with subscribers, science columnist Laurie Garrett and senior editor James Palmer discuss the potential global effects of the new coronavirus.
Transcript | FP Editors

 

How China’s Coronavirus Is Spreading—and How to Stop It
Studies are building toward a tentative clinical profile of the outbreak.
Report | Annie Sparrow

 

The Guardian
http://www.guardiannews.com/
Accessed 1 Feb 2020
Coronavirus outbreak
Paranoia and frustration as China places itself under house arrest
Cities are becoming ghost towns, while at the heart of the outbreak people are being disinfected after taking the bins out
Lily Kuo, Sat 1 Feb 2020

 

New Yorker
http://www.newyorker.com/
Accessed 1 Feb 2020
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 1 Feb 2020
Health
Researchers Are Racing to Make a Coronavirus Vaccine. Will It Help?
New technology and better coordination have sped up development. But a coronavirus vaccine is still months — and most likely years — away.
By Knvul Sheikh and Katie Thomas
Jan. 28

 

Washington Post
https://www.washingtonpost.com/
Accessed 1 Feb 2020
Governor opposes vote to overturn vaccine exemption law
AUGUSTA, Maine — Governor Janet Mills said Friday she opposes a referendum that would overturn Maine’s law eliminating religious and philosophical exemptions for vaccinations.
In a radio address, Mills, a Democrat, said she signed the law last year to better protect the health and welfare of residents across Maine.
Jan 31, 2020

Think Tanks et al

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 1 Feb 2020
[No new relevant content]

 

Center for Global Development
http://www.cgdev.org/page/press-center
Accessed 1 Feb 2020
January 31, 2020
Coronavirus and Low-Income Countries: Ready to Respond?
As the first suspected cases of the novel coronavirus 2019-nCoV are investigated in Ivory Coast and Angola, none of the 45 low-income countries that have undertaken a national preparedness assessment have been qualified as ready to respond.
Amanda Glassman

 

CSIS
https://www.csis.org/
Accessed 1 Feb 2020
Critical Questions
The Novel Coronavirus Outbreak
January 28, 2020 |
By J. Stephen Morrison, Jude Blanchette, Scott Kennedy, Stephanie Segal

 

Council on Foreign Relations
http://www.cfr.org/
Accessed 1 Feb 2020
January 30, 2020
Health
Refuge From Disease
Mitigating potential communicable disease in refugee populations is a subset of efforts for human rights, equality, and dignity. A basic multilateral framework could improve health care in these situ…
Report by Swee Kheng Khor and David L. Heymann
January 30, 2020

Public Health Threats and Pandemics
The World Health Organization
Since its postwar founding, the UN agency has garnered both praise and criticism for its response to international public health crises.
Backgrounder by CFR.org Editors

 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 1 Feb 2020
[No new relevant content]

Vaccines and Global Health: The Week in Review :: 1 Feb 2020

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

 pdf version A pdf of the current issue is available here: Vaccines and Global Health_The Week in Review_1 Feb 2020

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Vaccines and Global Health: The Week in Review :: 15 February 2020

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

 pdf version A pdf of the current issue is available here:Vaccines and Global Health_The Week in Review_15 Feb 2020

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy